Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-17

Clinical Trial Update: Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on de-intensification radiation therapy targeting involved-field in head and neck squamous cell carcinoma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Head and Neck Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED | Results posted: 2022-03-17